5 Health Care Provider Stocks to Buy Now

Advertisement

Five health care provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

Cross Country Healthcare, Inc. (CCRN) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. For more information, get Portfolio Grader’s complete analysis of CCRN stock.

Triple-S Management Corporation Class B (GTS) is seeing ratings go up from an A last week to a C this week. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR’s (FMS) ratings are looking better this week, moving up to a B from last week’s C. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. Shares of the stock have been trading at an exceptionally rapid pace, up twofold from the week prior. For more information, get Portfolio Grader’s complete analysis of FMS stock.

This week, Bio-Reference Laboratories, Inc. (BRLI) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.

DaVita HealthCare Partners Inc. (DVA) boosts its rating from a C to a B this week. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/03/5-health-care-provider-stocks-to-buy-now-ccrn-gts-fms-5/.

©2024 InvestorPlace Media, LLC